Amsino International Revenue and Competitors

Pomona, CA USA

Location

#4143

Growjo Ranking

Estimated Revenue & Valuation

  • Amsino International's estimated annual revenue is currently $61.5M per year.(i)
  • Amsino International's estimated revenue per employee is $305,945
  • Amsino International's total funding is $32M.

Employee Data

  • Amsino International has 201 Employees.(i)
  • Amsino International grew their employee count by 16% last year.

Amsino International's People

NameTitleEmail/Phone
1
Chairman, President and CEOReveal Email/Phone
2
CFOReveal Email/Phone
3
Chief Operating OfficerReveal Email/Phone
4
Sr. VP SalesReveal Email/Phone
5
VP Corporate AccountsReveal Email/Phone
6
SVP, Global Marketing & Business DevelopmentReveal Email/Phone
7
VP R&DReveal Email/Phone
8
VP Quality AssuranceReveal Email/Phone
9
VP Contract ManufacturingReveal Email/Phone
10
VP OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$24.1M9619%N/AN/A
#2
$9.5M3812%N/AN/A
#3
$4M16-11%N/AN/A
#4
$7.8M31-3%N/AN/A
#5
$5M20-5%N/AN/A
#6
$49.9M199-8%N/AN/A
#7
$16.8M67-17%$63.2MN/A
#8
$9.3M37-7%N/AN/A
#9
$36.6M14622%N/AN/A
#10
$64.3M2053%$502MN/A
Add Company

What Is Amsino International?

Established in 1993 in California, USA, Amsino is a leading medical device developer and manufacturer dedicated to advancing healthcare worldwide by developing, manufacturing, and marketing medical products that help improve the safety and effectiveness of patient care. Amsino product portfolio includes IV Therapy, Waste Fluid Managemanet, Urology, and Enteral products. Amsino products are distributed in the United States and more than 30 other countries worldwide. Please see complete product offering at: www.amsino.com

keywords:N/A

$32M

Total Funding

201

Number of Employees

$61.5M

Revenue (est)

16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$63M212-5%N/A
#2
$67.1M226-3%N/A
#3
$57.5M2553%N/A
#4
$53.4M2647%N/A
#5
$71.6M318-3%N/A